Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US exemption for Bt toxins in GM soybeans

The US EPA has established  tolerance exemptions for the Bt Cry2Ab2 and Cry1A.105 toxins in genetically modified insect-resistant soybeans. Monsanto had requested an extension to the tolerance exemption for Cry2Ab2 for maize and cotton to all food commodities and for an exemption for Cry1A.105 for all commodities but the Agency determined that the data provided only supported a safety finding for soybeans. Last month, the EPA proposed the registration of Monsanto's insect-resistant MON87751 soybeans for seed production purposes. They produce the Bt Cry1A.105 and Cry2Ab2 toxins for the control of lepidopteran pests. The USDA deregulated MON87751 soybeans in October 2014. The soybeans provide greater resistance to fall armyworms (Spodoptera frugiperda) than the MON87701 line, which produces the Cry1Ac toxin. That is a component of the insect-resistant and glyphosate-tolerant Intacta RR2 Pro (MON87701xMON89788) soybeans, which were introduced in Brazil in 2013.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022340

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel